Classifications: ANALGESIC, NONSTEROIDAL ANTI-INFLAMMATORY DRUG (NSAID)
Therapeutic: ANALGESIC, NSAID; ANTI-RHEUMATIC
Pregnancy Category: C; D third trimester
ACTION & THERAPEUTIC EFFECT
A long-acting nonsteroidal anti-inflammatory drug
(NSAID) is a nonnarcotic analgesic agent. This NSAID has peripheral analgesic
properties due to interfering with prostaglandin synthesis by inhibiting
cyclooxygenase (COX) isoenzymes, COX-1 and COX-2. Has analgesic and anti-inflammatory properties.
Treatment of osteoarthritis and rheumatoid
arthritis; mild to moderate pain.
Patients in whom aspirin or other NSAIDs precipitate
an acute asthmatic attack (bronchospasm), urticaria, angioedema, severe
rhinitis, or shock; active peptic ulcer, GI bleeding; severe salicylate
hypersensitivity; treatment of perioperative pain in CABG care; pregnancy
(category D third trimester).
History of upper GI disease; preexisting renal disease;
impaired renal or hepatic function; alcoholics; compromised cardiac function,
and other conditions associated with fluid retention; bone marrow suppression; geriatric
patients; hypertension; patients who may be adversely affected by prolonged
bleeding time; elderly; pregnancy (category C first and second trimester),
lactation. Safe use in children younger than 12 y not established.
Arthritis/Pain Conditions
Adult: PO 250–500 b.i.d. (max: 1500 mg/day)
- Give with water, milk, or food to reduce GI
irritation. Food causes slight reduction in absorption rate, but does not
affect total amount absorbed.
- Store at 15°–30° C (59°–86° F) in tightly closed
containers unless otherwise directed.
Body as a Whole: Hypersensitivity syndrome (fever, chills, rash, eosinophilia, changes in renal and hepatic function,
anaphylactic reactions with bronchospasm). CNS: Headache, drowsiness, insomnia, dizziness, vertigo, light-headedness, fatigue,
weakness, nervousness, confusion, disorientation. CV: Palpitation, tachycardia, peripheral edema. Special Senses: Tinnitus, hearing loss; blurred vision, reduced visual acuity, changes in color
vision, scotomas, corneal deposits, retinal disturbances. GI: Nausea, GI pain, flatulence, GI bleeding,
peptic ulcer, anorexia, eructation, cholestatic jaundice. Urogenital: Hematuria, proteinuria, interstitial
nephritis, renal failure. Hematologic:
Prolonged PT, anemia, decreased serum uric acid, transient elevations of liver function tests. Skin: Rash, toxic epidermal necrolysis, exfoliative
dermatitis, urticaria. Other:
Weight gain, hyperventilation, dyspnea, photosensitivity.
DIAGNOSTIC TEST INTERFERENCE
False elevation of serum salicylate levels.
Drug: ANTACIDS decrease
diflunisal absorption; aspirin and other NSAIDS increase
risk of GI bleeding; increases risk of warfarin-induced hypoprothrombinemia; increases methotrexate levels and toxicity.
Absorption: Readily from GI tract. Onset: 1 h. Peak: 2–3 h. Duration: 12 h. Distribution:
Probably crosses placenta; distributed into breast milk. Metabolism: In liver. Elimination:
In urine. Half-Life:
8–12h.
Diflunisal has been
associated with increased risk of serious, potentially fatal, CV thrombotic events
(i.e., MI and stroke). Risk may increase with duration of use and may be
greater in those with risk factors for CV disease.
Assessment & Drug Effects
- Monitor for and report promptly S&S of CV
thrombotic events (i.e., angina, MI, TIA, or stroke).
- Note: Although the antipyretic effect is mild,
chronic or high doses may mask fever in some patients.
- Monitor lab tests: With prolonged use, periodic
Hgb and Hct, PT/ INR, and renal function tests.
Patient & Family Education
- Seek immediate medical attention if you
experience S&S of adverse cardiovascular effects, such as chest pain,
shortness of breath, weakness, or slurring of speech.
- Report to prescriber onset of visual or auditory
problems.
- Check for and report peripheral edema and
unusual weight gain.
- Report immediately to prescriber S&S of
serious GI irritation, such as stomach pain, frequent indigestion, tarry
stools, or vomiting blood.
- Be alert for S&S of adverse skin reactions. Report
promptly development of rash, blisters, or other skin reactions.
- Do not drive or engage in other potentially
hazardous activities until reaction to drug is known.
- Do not take aspirin or other OTC analgesics
without permission of the prescriber.
Belum ada tanggapan untuk "Diflunisal Uses, Dosage, Side Effects"
Post a Comment